EFEarnings Feed

Filing detail

10-QCIK 0000913275

LYNX THERAPEUTICS INC 10-Q

Accession 0000913275-99-000018

Filed Aug 12, 8:00 PM ETSize 43.7 KB
View on sec.gov ↗Open company profile

Filed (ET)

Aug 12, 8:00 PM ET

Accepted

—

File size

43.7 KB

SEC accession

0000913275-99-000018

Filing details

Company
Solexa, Inc.
CIK
0000913275
Incorporated
DE
Entity type
operating

Related parties

  • filerCIK 0000913275

Documents

Attached files
2 items